Rightslink® by Copyright Clearance Center

Intérêt du siltuximab en alternative thérapeutique dans la maladie de Still de l’adulte multiréfractaire : à propos de 4 cas

Author:

Julie Moreau,Amélie Leurs,Emmanuel Ledoult,Sébastien Sanges,Pierre Quartier,Thibault Comont,David Launay,Eric Hachulla,Louis Terriou

Publication:

La Revue de Médecine Interne

Publisher:

Elsevier

Date:

July 2025

Please select your organization and/or account

Organization

Account

Please select your account from the above dropdown list. These accounts represent the offices, campuses, and other sites where your organization operates. Your account selection should match where you typically have an office or workspace. Even when you are traveling or temporarily working elsewhere, you should select the account that represents where you customarily work.

Cancel OK

Creative Commons

This is an open access article distributed under the terms of the Creative Commons CC-BY license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

You are not required to obtain permission to reuse this article.